Pharmacokinetics of the Protease Inhibitor Indinavir in Human Immunodeficiency Virus Type 1-Infected Children

The objective of this study was to evaluate the pharmacokinetics of indinavir in human immunodeficiency virus-infected children as part of a prospective, open, uncontrolled, multicenter study in The Netherlands. Human immunodeficiency virus type 1-infected children were monitored over 6 months of tr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Burger, David M., van Rossum, Annemarie M. C., Hugen, Patricia W. H., Suur, Marja H., Hartwig, Nico G., Geelen, Sibyl P. M., Scherpbier, Henriette J., Hoetelmans, Richard M. W., Vulto, Arnold G., de Groot, Ronald
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2001
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC90359/
https://ncbi.nlm.nih.gov/pubmed/11181346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.3.701-705.2001
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia